News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Benitec Limited (BLT.AX) Enters Into Binding Agreements For Treatment Of Chronic Hepatitis B Virus (HBV) With Biomics Biotechnologies In China


9/7/2009 10:44:37 PM

Melbourne, Sep 7, 2009 (ABN Newswire) - Benitec Limited (ASX:BLT)(PINK:BNIKF) has now entered into binding agreements with China based Biomics Biotechnologies Co. Ltd. As previously announced, the companies are collaborating on a DNA directed (ddRNAi) or vector expressed RNAi for the treatment of chronic hepatitis B virus (HBV) infection.

Read at ABN Newswire
Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES